Latest filing published 02 Nov 2026 for Neurocrine Biosciences INC, €1.9M.
Insider track record
No signal scores available.
George Morrow: trading record in brief
This profile gathers the share dealings of George Morrow in Neurocrine Biosciences Inc. We count 2 filings; the first trade dates from 30 October 2026 and the latest from 2 November 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 2 November 2026 with a transaction (€1.9M) in Neurocrine Biosciences Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to George Morrow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,700 shares@ US$146.10CommonSEC144:0001950047-26-010581
- 300 shares@ US$146.380.0003% mcap100.0% of flowCommonSEC144:0001950047-26-010505
2 of 2 declarations
